Cadonilimab (PD-1/CTLA-4 Bispecific Blockade) and Chemoradiotherapy in Nasopharyngeal Carcinoma (GEMSTONE)

Clinical trial NCT05587374 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT05587374
Sponsor: Sun Yat-sen University
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Nasopharyngeal Carcinoma Nasopharyngeal Cancer

Start date: 2023-08-01
Primary completion: 2027-08-01
Enrollment: 490

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.